, are present in both live and killed vaccines, indicating that certain poorly characterized aspects of live microorganisms, not incorporated in dead vaccines, are particularly effective at inducing protective immunity. Here we show that the mammalian innate immune system can directly sense microbial viability through detection of a special class of viabilityassociated PAMPs (vita-PAMPs). We identify prokaryotic messenger RNA as a vita-PAMP present only in viable bacteria, the recognition of which elicits a unique innate response and a robust adaptive antibody response. Notably, the innate response evoked by viability and prokaryotic mRNA was thus far considered to be reserved for pathogenic bacteria, but we show that even non-pathogenic bacteria in sterile tissues can trigger similar responses, provided that they are alive. Thus, the immune system actively gauges the infectious risk by searching PAMPs for signatures of microbial life and thus infectivity. Detection of vita-PAMPs triggers a state of alert not warranted for dead bacteria. Vaccine formulations that incorporate vita-PAMPs could thus combine the superior protection of live vaccines with the safety of dead vaccines.
We hypothesized that the innate immune system might sense the most fundamental characteristic of microbial infectivity, microbial viability itself, and activate a robust immune response regardless of the presence of more specialized factors that regulate microbial virulence 7 . To study the sensing of bacterial viability without the compounding effects of replication or virulence factors, we used thymidine auxotrophs of nonpathogenic Escherichia coli K12, strain DH5a (hereafter called thyA 2 E. coli). Viable and heat-killed thyA 2 E. coli similarly activated nuclear factor-kB (NF-kB) and mitogen-activated protein kinase p38 (Supplementary Fig. 1 ) in murine bone-marrow-derived macrophages and elicited production of similar amounts of interleukin-6 (IL-6) and tumour necrosis factor-a (TNF-a) (Fig. 1a) . In contrast, viable thyA 2 E. coli induced higher levels of IFN-b than heat-killed thyA 2 E. coli or lipopolysaccharide (LPS) (Fig. 1b) , and only viable thyA 2 E. coli induced IL-1b secretion ( Fig. 1c and Supplementary Fig. 2 ). Pro-IL-1b transcription was equally induced by both viable and heat-killed thyA 2 E. coli (Fig. 1c) , indicating that viable bacteria specifically elicit cleavage of pro-IL-1b. This process is catalysed by caspase-1 in Nod-like receptor (NLR)-containing inflammasome complexes, the assembly of which can be triggered by the activity of bacterial virulence factors 10, 11 . Notably, avirulent viable but not heat-killed thyA 2 E. coli induced inflammasome activation and pro-caspase-1 cleavage (Fig. 1d) . Finally, viable but not heat-killed thyA 2 E. coli induced caspase-1-dependent inflammatory cell death, termed pyroptosis 10, 11 , resulting in the release of lactate dehydrogenase (LDH) (Fig. 1e ) and the appearance of 7-amino-actinomycin D (7AAD) 1 annexin-V 2/low cells (Fig. 1f) . Similar responses were observed in peritoneal macrophages and both splenic and bone-marrow-derived dendritic cells ( Supplementary Fig. 2b ). Killing thyA 2 E. coli by ultraviolet irradiation, antibiotics, or ethanol also selectively abrogated IL-1b secretion and pyroptosis without affecting IL-6 production ( Fig. 1g and Supplementary Fig. 3 ), indicating that a general determinant associated with bacterial viability is detected.
To determine whether pathogenic bacteria can also activate the inflammasome in the absence of virulence factors, we studied attenuated strains of selected pathogens: Shigella flexneri virulence plasmid-cured strain BS103 12 , Salmonella enterica serovar Typhimurium SL1344 DSpi1DSpi2, lacking the Salmonella pathogenicity islands SPI-1 and SPI-2 (ref. 10) , and Listeria monocytogenes DHlyDfliC, lacking listeriolysin O and flagellin 10 . These mutants induced IL-1b production at levels comparable to those induced by thyA 2 E. coli (Fig. 1h) , but lower and with slower kinetics than their pathogenic counterparts (Supplementary Fig. 4 ). IL-1b production was abolished when these bacteria were killed, whereas IL-6 production was similar (Fig. 1h) . Thus, immune cells detect universal characteristics of viability different from virulence factors.
Caspase-1 activation, pyroptosis and IL-1b production in response to thyA 2 E. coli were abrogated in macrophages deficient for NLRP3 or for the inflammasome adaptor apoptosis speck protein with caspase recruitment (ASC or PYCARD) 11 ( Fig. 1i, j) , whereas NLRC4 was dispensable ( Supplementary Fig. 5 ). Pyroptosis and IL-1b production induced by viable thyA 2 E. coli were abrogated in Casp1 2/2 macrophages ( Fig. 1j ) and suppressed by inhibitors for caspase-1, but not caspase-8 ( Supplementary Fig. 6 ).
Induction of IFN-b mRNA and protein by viable thyA 2 E. coli required the Toll-like receptor (TLR) adaptor TRIF 9 ( Fig. 2a, b ) and downstream interferon regulatory factor-3 (IRF3) 9 ( Supplementary  Fig. 7 ), but not MyD88, the main TLR adaptor 9 ( Fig. 2a, b) . In contrast, transcription of pro-IL-1b was largely dependent on MyD88. Consequently, Myd88 2/2 cells secreted no IL-1b (Fig. 2c, d ), whereas pyroptosis and caspase-1 cleavage were intact (Fig. 2e, f) . Notably, although TRIF was dispensable for pro-IL-1b transcription (Fig. 2c) , Trif 2/2 cells failed to secrete IL-1b (Fig. 2d) , were protected from pyroptosis ( Fig. 2e) and did not activate caspase-1 (Fig. 2f) . These findings revealed an unexpected role for TRIF in NLRP3 inflammasome activation in response to viable thyA 2 E. coli. In contrast, pyroptosis induced by pathogenic S. enterica Typhimurium 10 proceeded independently of TRIF ( Supplementary Fig. 8 ). Differential involvement of TRIF, together with differences in magnitude and kinetics of the response ( Fig. 1h and Supplementary Fig. 4 ), indicated that inflammasome activation in response to virulence factors occurs in a manner distinct from that to viability.
Genome-wide transcriptional analysis of wild-type and Trif
2/2
macrophages before and after phagocytosis of viable thyA 2 E. coli showed differential regulation of several clusters of genes (Supplementary Fig. 9 ) including IFN-regulated genes, as expected 9 ( Fig. 2a, b and Supplementary Fig. 10a ), whereas most of the Rel/NF-kB target genes were comparable ( Supplementary Fig. 10b ). Nlrp3 expression was induced independently of TRIF (Fig. 2g, h ), and negative regulators of inflammasome activity, such as those encoded by Mediterranean fever (Mefv), Nlrp10 and Casp12 genes, were also unchanged or expressed at higher levels in wild-type macrophages (Fig. 2g) , possibly due to negative feedback. Thus, the role of TRIF in inflammasome activation upon phagocytosis of viable thyA 2 E. coli is not explained by transcriptional control of inflammasome components (so called priming 11 ). Furthermore, ATP and reactive oxygen species (ROS) 11, 13 , known activators of the NLRP3 inflammasome, were not involved, as deficiency for P 2 X 7 R, which is required for ATP-mediated NLRP3 activation, did not affect pyroptosis or IL-1b production (Supplementary Fig. 11a, b) , and ROS accumulated equally in response to viable and heat-killed thyA 2 E. coli independently of TRIF ( Supplementary  Fig. 11c ). 
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Injection of viable and heat-killed thyA 2 E. coli into mice induced similarly high serum levels of IL-6 (Fig. 2i) . In contrast, circulating IL1b was detected only in mice infected with viable bacteria (Fig. 2i) , whereas IFN-b levels were undetectable in all groups (data not shown). Confirming our results in vitro, production of IL-1b (but not IL-6) in vivo also required TRIF, ASC and NLRP3 (Fig. 2i) . Injection of non-pathogenic S. enterica Typhimurium induced serum IL-1b levels comparable to those elicited by thyA 2 E. coli, which similarly depended on TRIF ( Supplementary Fig. 12 ). Although pathogenic S. enterica Typhimurium elicited higher levels of serum IL-1b than non-pathogenic Salmonella, this response was also severely reduced in Trif 2/2 mice, suggesting a previously unappreciated role for TRIF in Salmonella infection ( Supplementary Fig. 12 ). Importantly, deficiency in TRIF, ASC and NLRP3 impaired bacterial clearance during systemic infection with replication-sufficient non-pathogenic E. coli (Fig. 2j ). This failure was more dramatic in Trif 2/2 than in Asc
or Nlrp3 2/2 mice, possibly due to the central upstream role of TRIF in inflammasome activation and IFN-b production.
The ability to sense microbial viability through pathways downstream of pattern recognition receptors indicates the existence of vitaPAMPs; that is, PAMPs associated with viable but not dead bacteria. In contrast to LPS and genomic DNA, which remained constant after killing thyA 2 E. coli with heat, total bacterial RNA was rapidly lost (Fig. 3a, b and Supplementary Fig. 13 ). Total RNA content was also lost with antibiotic treatment, and little ribosomal RNA (rRNA) remained after killing with ultraviolet irradiation and ethanol ( Supplementary Fig. 14 ). Only fixation with paraformaldehyde (PFA) efficiently killed the bacteria (not shown) while preserving total RNA content ( Supplementary Fig. 15a ). Remarkably, unlike bacteria killed by other means, PFA-killed bacteria induced pyroptosis and IL-1b production to levels similar to those induced by viable bacteria ( Supplementary Fig. 15b ). Thus, the presence or absence of RNA correlated with the ability to activate pathways involved in sensing viability.
These results indicate that prokaryotic RNA represents a labile PAMP closely associated with bacterial viability that might signify microbial life to the immune system. Indeed, addition of purified total bacterial RNA fully restored the ability of heat-killed thyA 2 E. coli to induce pyroptosis, IL-1b and IFN-b production (Fig. 3c ). These responses were dependent on TRIF, NLRP3 and caspase-1, just as those responses elicited by viable bacteria (Fig. 3d compared to Figs 1j and 2a-f). The NLRP3 inflammasome mediates recognition of viral RNA during influenza A infection 14 . Together with our results and those of others 15 , this suggests a more general role for NLRP3 in responses to RNAs of microbial origin. RNA can activate the NLRP3 inflammasome when delivered into the cytosol (where NLRP3 is found) with transfection reagents 15 . In contrast, inflammasome activation by the combination of total bacterial RNA and dead thyA 2 E. coli did not require RNA transfection (Fig. 3c, d) . Administration of total E. coli RNA alone or in combination with LPS (to mimic an E.-coli-derived PAMP plus RNA) had little effect on NLRP3 inflammasome activation unless the RNA was delivered to the cytosol using Lipofectamine (Supplementary Fig. 16 ) or in combination with ATP, as reported previously 15 . Thus, phagocytosis of viable bacteria is a natural context of bacterial-RNA-mediated NLRP3 inflammasome activation.
These findings raised the question as to how vita-PAMPs in phagolysosomes gain access to cytosolic receptors such as NLRP3 in the absence of invasion, auxiliary secretion systems or pore-forming toxins. To address this question, we exploited the pH-sensitive excitation spectrum of fluorescein: the acidic pH in phagolysosomes quenches fluorescence whereas release into the pH-neutral cytosol allows a regain in fluorescence 16 . Phagocytosis of avirulent thyA 2 E. coli in the presence of fluorescein-conjugated dextran (Fdx) consistently induced low-level release of Fdx into the cytosol of macrophages (Fig. 3e, f and Supplementary Fig. 17 ). This indicates that phagosomes carrying E. coli exhibit intrinsic leakiness, a property previously described for particles such as beads and crystals that induce phagolysosomal destabilization 16, 17 . Interestingly, killed E. coli also induced Fdx release, although to a slightly lower extent than viable E. coli (Fig. 3e, f) , demonstrating that phagosomal leakage occurs independently of bacterial viability. Therefore, RNA from viable 
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bacteria could gain access to cytosolic receptors via intrinsic phagosomal leakage. These results may also explain the reported ability of phagosome-degraded mutants of Listeria monocytogenes or Staphylococcus aureus to induce a transcriptional response dependent on cytosolic NLRs 18, 19 . Digestion of total RNA from E. coli with exonuclease RNase I and double-stranded RNA (dsRNA)-specific endonuclease RNase III abrogated LDH and IL-1b release, whereas DNase treatment had no effect (Fig. 4a) . Of the E. coli RNA species, mRNA most potently induced pyroptosis as well as production of IL-1b and IFN-b. Small RNA (sRNA), or the most abundant RNA, ribosomal RNA (rRNA), had little or no detectable effects (Fig. 4b and Supplementary Fig. 18 ). Escherichia coli rRNA undergoes extensive modifications not found in mRNA 20 , which may underlie the differential activity of these RNA species. The relative amount of mRNA was ,1% of the total RNA and accordingly, mRNA was approximately 100-fold more effective than total RNA (Figs 3c and 4a, b and Supplementary Fig. 18 ).
In-vitro-transcribed single-stranded mRNA of the E. coli Gro operon ( Supplementary Fig. 19a, b) , which is strongly expressed upon phagocytosis of bacteria 21 , induced caspase-1 cleavage and subsequent pyroptosis and IL-1b production when phagocytosed together with heat-killed thyA 2 E. coli (Fig. 4c, e and Supplementary Fig. 19c-e) . The single-stranded Gro mRNA sequence had a predicted secondary structure with regions of high probability for base pairing (Fig. 4d) , consistent with susceptibility of the stimulatory activity to RNase III treatment (Fig. 4a) . Indeed, fully dsGro mRNA ( Supplementary Fig.  19b ) induced responses similar to single-stranded Gro mRNA of the appropriate length ( Fig. 4e and Supplementary Fig. 19d ). Other transcripts also induced such responses, showing that the immunostimulatory property is independent of RNA sequence (Fig. 4f) .
Notably, eukaryotic RNA was unable to elicit the responses induced by E. coli mRNA (Fig. 4b) . Unlike eukaryotic mRNA, triphosphate moieties at the 59 end of bacterial mRNAs are not capped with 7-methyl-guanosine (7m 7 G) 22 , and might betray the prokaryotic origin of these transcripts 23 . However, neither treatment with calf intestinal phosphatase (CIP) nor capping affected the activity of Gro mRNA during phagocytosis of heat-killed thyA 2 E. coli (Fig. 4g) . The stimulatory activity of purified E. coli total RNA or mRNA was also unaltered by CIP treatment (Supplementary Fig. 20a, b) , arguing against a role for the RNA helicase retinoic acid inducible gene-I (RIG-I), which can induce interferon and IL-1b production but requires 59-triphosphates for activation ( Supplementary Fig. 20c ) 23 . Moreover, TRIF and NLRP3 are dispensable for RIG-I function but are required for the stimulatory activity of bacterial RNA (Figs 2a, b  and 3d) . Interestingly, RNA can induce RIG-I-dependent IFN-b during infection with an invasive intracellular bacterium 24 , indicating that the nature of microbial pathogenesis and the cellular context in which bacterial RNA is recognized may determine the choice of innate sensors engaged. In contrast to 59-triphosphate removal, adding polyadenylyl groups to the 39 end of Gro mRNA or purified E. coli mRNA abrogated IL-1b secretion and pyroptosis ( Fig. 4g and Supplementary Fig. 21 ). Thus, absence of 39-polyadenylation 22 may allow specific detection of prokaryotic mRNA during infection. Additional features may distinguish self from microbial RNAs such as internal naturally occurring nucleoside modifications in eukaryotic RNA [25] [26] [27] . To test the impact of vita-PAMPs on adaptive immunity, we immunized mice with either viable or dead thyA 2 E. coli, or a combination of dead thyA 2 E. coli and purified total bacterial RNA ( Supplementary  Fig. 22 ). Whereas all three vaccines induced similar polyclonal anti-E. coli IgM responses, production of class-switched IgG subclasses was strongly enhanced in response to vaccination with viable compared to killed E. coli (Fig. 4h) . Adding total bacterial RNA to killed thyA 2 E. coli elevated IgG1, IgG2c, IgG2b and IgG3 antibody titres to or above the levels in mice immunized with viable thyA 2 E. coli. Thus, innate detection of bacterial viability leads to robust activation of a humoral adaptive response. These findings indicate that bacterial RNA can augment killed vaccines to perform as well as live ones.
Our findings reveal an inherent ability of the immune system to distinguish viable from dead microorganisms. The presence of live bacteria in sterile tissues, regardless of whether these (still) express Supplementary Fig. 22 ). Class-specific anti-E. coli antibody serum titres at 25 days are shown. *, P # 0.05; **, P # 0.01; ***, P # 0.001. All bars represent mean 6 s.e.m.
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virulence factors, poses an acute threat that must be dealt with by an aggressive immune response. Dead bacteria, on the other hand, would signify a successful immune response that can now subside. Detection of vita-PAMPs within sterile tissues signifies microbial viability. Other vita-PAMPs may exist in the form of second messengers like cyclic diadenosine or di-guanosine monophosphates 7, 28 or quorum-sensing molecules 7 . The extent to which vita-PAMPs contribute to the host response during natural infection with pathogenic bacteria, relative to other stimuli such as the activity of virulence factors, is an important issue that requires further investigation. Given that bacteria tightly regulate their virulence via multiple mechanisms in response to different environmental signals and inside a host organism during infection 29, 30 , detection of invariant vita-PAMPs essential to bacterial survival may be a non-redundant fail-safe strategy for host protection.
METHODS SUMMARY
Cells were infected with E. coli DH5a thyA 2 at a multiplicity of infection of 20 for 24 h unless stated otherwise. Supernatants were assayed for cytokines by ELISA. Genome-wide transcriptional analysis of murine bone-marrow-derived macrophages (BMMs) at 0, 1, 3 and 6 h after infection was carried out on Affymetrix GeneChip Mouse Gene 1.1 ST 24-array plates. Phagosomal leakage in BMMs was detected by measuring Fdx release using a modified method previously described 16 . In brief, BMMs were treated with thyA 2 E. coli in the presence of 0.167 mg ml 21 Fdx and imaged with excitation at 440 nm (pH insensitive) and 485 nm (pH sensitive). Fluorescence intensity ratios at 485 nm/440 nm were converted into pH maps and the percentage of Fdx release calculated (total intensity of pixels containing released Fdx/total Fdx intensity). Bacterial RNA was extracted from E. coli using the e.z.n.a RNA kit (Omega) and in vitro transcription of bacterial genes carried out using the MEGAscript kit (Ambion) followed by DNase digestion and RNA purification using the MEGAclear kit (Ambion).
RNA polyadenylation was performed with the poly(A)-tailing kit (Ambion).
Vaccinations were performed as a prime-boost regimen (see Methods). C57BL/ 6J and P2rx7 2/2 mice were purchased from the Jackson Laboratory. Myd88
and Trif 2/2 mice were provided by S. Akira, Trif 
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Cells. Bone-marrow-derived dendritic cell (BMDC) cultures were grown as previously described 31 in RPMI 1640 supplemented with granulocyte-macrophage colony-stimulating factor (GM-CSF) and 5% fetal bovine serum (FBS), plus 100 mg ml 21 penicillin, 100 mg ml 21 streptomycin, 2 mM L-glutamine, 10 mM HEPES, 1 nM sodium pyruvate, 1% MEM non-essential amino acids, and 2.5 mM bmercaptoethanol (all Sigma). Semi-adherent cells were harvested on ice on day 5 and re-plated immediately in fresh RPMI 1640 medium containing 10% FBS at 5 3 10 5 cells per well in 24-well tissue-culture-treated plates. Stimuli were added immediately after re-plating in the same medium and the cells were centrifuged for 2 min at 2,000 r.p.m. Murine macrophages were derived from the bone marrow (BMMs) of C57BL/6J, Myd88
, Asc 2/2 or Casp1 2/2 mice, as described previously 32 , in RPMI 1640 supplemented with M-CSF and 10% FBS, plus 100 mg ml 21 penicillin, 100 mg ml 21 streptomycin, 10 mM HEPES and 1 nM sodium pyruvate (all Sigma). For some experiments macrophages were derived from the bone marrow of Irf3 2/2 or P2rx7 2/2 mice. Peritoneal macrophages were harvested 72 h after intraperitoneal injection of 1 ml thioglycollate (BD Bioscience), grown overnight in RPMI 1640 medium supplemented with 10% FBS and 100 mg ml 21 penicillin and 100 mg ml 21 streptomycin, hereafter referred to as 'complete medium'. Mouse embryonic fibroblasts (MEFs) deficient for RIG-I (RIG-I 2/2 ) were provided by A. Ting with permission from S. Akira, and grown in DMEM medium containing 10% FBS and 100 mg ml 21 penicillin, 100 mg ml 21 streptomycin. Mice. C57BL/6J and P2rx7 2/2 mice were purchased from Jackson Laboratories.
Myd88
2/2 and Trif 2/2 mice were originally provided by S. Akira; Myd88 2/2 and Trif 2/2 mice were interbred to homozygosity to generate Trif
mice, and were provided by R. Medzhitov. Nlrp3
2/2
, Asc 2/2 or Casp1 2/2 bone marrow was provided by B. Ryffel and mice for in vivo studies were acquired from R. Flavell (through Millenium) and have been described previously 33, 34 . Irf3 2/2 mice were provided by C. B. Lopez and were previously described 35 . We used 8-10-week-old animals for all experiments. All experiments were approved by the institutional ethics committee and carried out in agreement with the 'Guide for the Care and Use of Laboratory Animals' (NIH publication 86-23, revised 1985). Bacteria. Escherichia coli K12, strain DH5a were purchased from Invitrogen. Naturally occurring thymidine auxotrophs (thyA 2 ) were selected on LuriaBertani (LB) agar plates containing 50 mg ml 21 trimethoprim and 500 mg ml 21 thymidine (both Sigma). Auxotrophy was confirmed by inoculation and overnight culture of single colonies in LB medium. thyA 2 E. coli grew only in the presence of thymidine and were resistant to trimethoprim. For phagocytosis experiments, thyA -E. coli were grown to mid-log phase, washed three times in phosphate buffered saline (PBS) to remove thymidine and LB salts before addition to cells. For heat killing, thyA 2 E. coli were grown to log phase, washed and re-suspended in PBS at an optical density at 600 nm (OD 600 ) of 0.6, and subsequently incubated at 60 uC for 60 min. thyA 2 heat-killed E. coli were stored up to 18 h at 4 uC or used immediately after cooling. Efficient killing was confirmed by overnight plating on thymidine/trimethoprim-supplemented LB-agar plates. For gentamicin killing, thyA 2 E. coli were grown to mid-log phase, washed and re-suspended in LB medium containing thymidine, trimethoprim and 50 mg ml 21 gentamicin sulphate and incubated in a shaking incubator at 37 uC overnight. Ethanol killing was carried out by re-suspending log phase thyA 2 E. coli in 70% ethanol for 10 min, followed by extensive washing in PBS. For ultraviolet killing, log phase thyA 2 E. coli were re-suspended in PBS at an OD 600 of 0.6, ultraviolet-irradiated with 1,000 mJ cm 22 in a Petri dish followed by washing with PBS. Paraformaldehyde (PFA) fixation was performed by re-suspending log-phase thyA 2 E. coli in 4% PFA in PBS for 10 min followed by extensive washing and re-suspension in PBS. Shigella flexneri virulence plasmid-cured strain BS103 was provided by M. B. Goldberg 12, 36 . thyA 2 S. flexneri were selected similarly to thyA 2 E. coli. D. M. Monack provided Salmonella enterica serovar Typhimurium, strain SL1344 DSpi1DSpi2, lacking the Salmonella pathogenicity island SPI-1 and SPI-2 type-III secretion systems 37 . SL1344 DSpi1DSpi2 was grown in LB medium containing 25 mg ml 21 kanamycin and 12 mg ml 21 tetracycline. Listeria monocytogenes DHlyDfliC lacking listeriolysin O (LLO) and flagellin expression were provided by D. Portnoy 38 .
Treatment of macrophages and dendritic cells with viable and killed bacteria.
Macrophages were detached and re-plated 4 h before the experiment. BMDCs were re-plated immediately before addition of bacteria or soluble ligands. Unless stated otherwise, bacteria were used at a multiplicity of infection of 20. All experiments were carried out in antibiotic-free 'complete medium'. One hour after addition of bacteria, penicillin (100 mg ml
21
) and streptomycin (100 mg ml 21 ) were added to the medium to kill any remaining extracellular bacteria. Alternatively, gentamicin sulphate (50 mg ml
) was used. We also compared this approach to washing the cells and replacing the antibiotic-free medium with penicillin/streptomycin containing medium after 1 h and found no differences with regards to the cellular responses measured. Supernatants were collected 24 h after the addition of the bacteria unless stated otherwise in the figure legends. Cytokine enzyme-linked immunosorbent assays. Supernatants from cultured BMMs or BMDCs were collected at 24 h after stimulation or at the times indicated. Enzyme-linked immunosorbent assay (ELISA) antibody pairs used for IL-6, IL-1b and TNF-a were as listed below. All ELISA antibodies were used at 2 mg ml 21 capture and 0.5 mg ml 21 detection, with the exception of IL-6 capture, which was used at 1 mg ml
. Detection antibodies were biotinylated and labelled by streptavidin-conjugated horseradish peroxidase (HRP), and visualized by the addition of o-phenylenediamine dihydrochloride (Sigma) (from tablets) or 3,39, 5,59-tetramethylbenzidine solution (TMB, KPL). Colour development was stopped with 3 M H 2 SO 4 or TMB-Stop Solution (KPL), respectively. Recombinant cytokines served as standards and were purchased from Peprotech. Absorbances at 492 or 450 nm were measured, respectively, on a tunable microplate reader (VersaMax, Molecular Devices). Cytokine supernatant concentrations were calculated by extrapolating absorbance values from standard curves where known concentrations were plotted against absorbance using SoftMax Pro 5 software. Capture/detection antibody pairs were as follows. IL-6, MP5-20F3/MP5-32C11 (BDPharmingen); IL-1b, B12/rabbit polyclonal antibody (eBioscience); TNF-a, TN3-19/rabbit polyclonal antibody (eBioscience). IFN-b production was measured from supernatants using the VeriKine Mouse IFN-Beta ELISA Kit (PBL Interferon source) following manufacturer's instructions. Anti-E. coli antibody ELISA. 96-well microtitre plates were coated overnight with E. coli lysates (3 mg ml
) that we generated from log-phase cultures of thyAtranscriptional analysis. RNA integrity was checked on an Agilent 2100 Bioanalyser (Agilent Technologies) with 6000 Nano Chips. RNA was judged as suitable only if samples showed intact bands of 18S and 28S ribosomal RNA subunits, displayed no chromosomal peaks or RNA degradation products, and had a RNA integrity number (RIN) above 8.0.
One-hundred nanograms of RNA were used for whole-transcript cDNA synthesis with the Ambion WT expression kit (Applied Biosystems). Hybridization, washing and scanning of an Affymetrix GeneChip Mouse Gene 1.1 ST 24-array plate was carried out according to standard Affymetrix protocols on a GeneTitan instrument (Affymetrix).
Packages from the Bioconductor project, integrated in an in-house developed management and analysis database for microarray experiments, were used for analysis of the scanned arrays 39 . Arrays were normalized using the Robust Multi-array Average method 40, 41 . Probe sets were defined according to ref. 42 . With this method probes are assigned to unique gene identifiers, in this case Entrez IDs. The probes on the Gene 1.1 ST arrays represent 19,807 genes that have at least 10 probes per identifier. For the analysis, only genes that had an intensity value of .20 on at least two arrays were taken into account. In addition, the interquartile range of log 2 intensities had to be at least 0.25. These criteria were met by 9,921 genes. Changes in gene expression are represented as signal log ratios between treatment and control. Multiple Experiment Viewer software (MeV 4.6.1) was used to create heatmaps 43, 44 . Genes were clustered by average linkage hierarchical clustering using Pearson correlation. Significantly regulated genes were identified by intensity-based moderated t-statistics 45 . Obtained P-values were corrected for multiple testing by a false discovery rate method 46 . IFN-regulated genes were identified using the Interferome database (http:// www.interferome.org) 47 and grouped in a heat map. Rel/NF-kB target genes were identified using another online database (http://bioinfo.lifl.fr/NF-KB/) which compiles Rel/NF-kB target genes identified by various groups 48 (http://people. bu.edu/gilmore/nf-kb/index.html). Inflammasome-related genes were compiled based on the current literature 11, 49 . Measuring release from bacterial phagosomes. Measurement of fluoresceindextran (Fdx) release from macrophage phagosomes was performed using a modified method described previously 16 . BMMs were plated onto Mat-tek coverslip dishes (MatTek Corp.) and incubated overnight. BMMs were stimulated with viable or gentamicin-killed red fluorescent protein (RFP)-expressing thyA 2 E. coli in the presence of 0.167 mg ml 21 Fdx in 200 ml of medium. After 120 min of co-culture, additional Fdx and gentamicin containing medium was added to the coverslip dishes to prevent drying and to prevent bacterial overgrowth. Cells were imaged after 2, 4 and 8 h to measure release of Fdx. Microscopic imaging was performed on an IX70 inverted microscope (Olympus) equipped with an X-cite 120 metal halide light source (EXFO) and excitation and emission filter wheels. Phase contrast and two fluorescent images were acquired for each field of cells. The fluorescent images used the same emission settings, but used different excitation band-pass filters. Fdx fluorescence intensity using an excitation filter centred at 440 nm is relatively insensitive to pH, whereas fluorescence intensity using an excitation filter centred at 485 nm is very sensitive to pH. The ratio of fluorescence intensity at 485 nm divided by 440 nm was converted to into pH maps using calibration curves generated by imaging BMMs with Fdx-containing compartments at a series of fixed pH conditions. As described previously 16 , pixels with pH above 5.5 were designated as representing Fdx which has been released from endolysosomal compartments. The percentage of Fdx release was calculated by dividing the total intensity of pixels containing released Fdx by the total Fdx intensity for each cell. Infections and vaccinations. For measurements of systemic cytokine levels, C57BL/6J wild-type, Trif 2/2 , Asc 2/2 or Nlrp3 2/2 mice were injected with 1 3 10 9 viable or 5 3 10 9 heat-killed thyA 2 E. coli, respectively. Blood samples were drawn 6 h after infection, and cytokine concentrations were measured by ELISA. For determination of bacterial clearance, we infected mice with 1 3 10 8 viable replication-sufficient E. coli by intraperitoneal injection. Mice were monitored daily and moribund animals were killed according to humane criteria established and approved by our institutional IACUC committee. After 60 h, animals were killed and the spleens were explanted, homogenized, serially diluted and plated on LBagar plates overnight followed by colony forming units (c.f.u.) counting.
For vaccinations, we followed a prime-boost regimen as shown in the schematic in Fig. 4h that was adopted from a previous study 50 . In brief, mice received an initial vaccination intraperitoneally with 5 3 10 7 c.f.u. of viable or heat-killed thyA 2 E. coli or a combination of 5 3 10 7 c.f.u. heat-killed thyA 2 E. coli and 30 mg of purified E. coli total RNA, followed by two boosts (5 3 10 6 c.f.u.) after 10 and 20 days. Polyclonal class-specific anti-E. coli antibody production was measured in the serum after 25 days by ELISA. Bacterial RNA. Total bacterial RNA was isolated from thyA 2 E. coli using the e.z.n.a. Bacterial RNA Kit (Omega Bio-Tek), following the manufacturer's instructions. Contaminating DNA was removed by DNase digestion (TURBO DNase, Ambion/Applied Biosystems). Alternatively, total purified E. coli (DH5a) RNA was purchased from Ambion/Applied Biosystems, and similar results were obtained. Fractionation of bacterial RNA species was performed as follows. First, ribosomal 16S and 23S RNA (rRNA) was removed by a magnetic bead-based capture hybridization approach using the MICROBExpress kit (Ambion/Applied Biosystems). The enriched RNA was then separated into messenger RNA (mRNA) and small RNA (sRNA, including 5S rRNA) using the MEGAClear kit (Ambion/ Applied Biosystems). All separated RNA fractions were precipitated with ammonium acetate and re-suspended in nuclease-free water. RNA concentration and purity were determined by measuring the absorbance at 260/280 and 260/230 nm. RNA preparations were further visualized by 1% agarose gel electrophoresis. In vitro RNA transcription. The E. coli Gro operon encoding the bacterial chaperonins GroEL and GroES, the GTPase Era operon or the DNA polymerase III operon were PCR amplified from genomic DNA isolated from thyA 2 E. coli using primer pairs containing a T7 promoter sequence (T7) in either the FW or both FW and RV primer. Gro-FWT7 59-TAATACGACTCACTATAGGGCACC AGCCGGGAAACCACG-39; Gro-RVT7 59-TAATACGACTCACTATAGGAA AAGAAAAACCCCCAGACAT-39; Gro-RV 59-AGATGACCAAAAGAAAAA CCCCCAGACATT-39; Era-FWT7 59-TAATACGACTCACTATAGGGCATA TGAGCATCGATAAAAGTTAC-39; Era-RV 59-TTTAAAGATCGTCAACGT AACCGAG-39; DNApol-FWT7 59-TAATACGACTCACTATAGGGATGTCTG AACCACGTTTCGT-39; DNApol-RV 59-AGTCAAACTCCAGTTCCACCTGC TCCGAA-39.
PCR fragments were purified using the Nucleospin Extract II PCR purification kit (Macherey-Nagel), and used as DNA templates for in vitro transcription. In vitro transcription was performed using the MEGAscript kit T7 (Ambion/Applied Biosystems) following the manufacturer's instructions. DNA templates generated with Gro-FWT7 and Gro-RV primers only contained a T7 promoter site in the sense strand and yielded single-stranded RNA, whereas PCR templates generated with Gro-FWT7 and Gro-RVT7 primers contained T7 promoter sequences in both strands, allowing transcription of two complementary strands, yielding double-stranded RNA. For generation of 59-capped RNA, m7G(59)ppp(59)G cap analogue (Ambion/Applied Biosystems) was included in the transcription reaction at a GTP:cap ratio of 1:4. RNA digestion, dephosphorylation and polyadenylation. In-vitro-transcribed Gro RNA, total E. coli RNA or E. coli mRNA were digested using RNase I (Promega) and RNase III (Ambion/Applied Biosystems). To remove 59-triphosphates, RNA dephosphorylation was performed by incubating 10 mg in-vitro-transcribed RNA or total E. coli RNA or 1 mg of E. coli mRNA with 30 U of calf intestinal alkaline phosphatase (CIP, New England Biolabs) for 2 h at 37 uC, as described previously 51 . Polyadenylation of in-vitro-transcribed and purified bacterial mRNA was performed using the poly(A) Tailing kit (Ambion) following the manufacturer's instructions. Transfection of macrophages and MEFs. For direct cytosolic delivery of total purified E. coli RNA or in-vitro-transcribed Gro RNA, 5 3 10 5 BMMs or 2 3 10 5
